Skip to main content
PMC home page
Journal of Virology logoLink to Journal of Virology
. 1977 Mar;21(3):974–980. doi: 10.1128/jvi.21.3.974-980.1977

Natural immunity in mice to the envelope glycoprotein of endogenous ecotropic type C viruses: neutralization of virus infectivity.

J N Ihle, B Lazar
PMCID: PMC515636  PMID: 191656

Abstract

The ability of naturally immune mouse sera to neutralize ecotropic AKR murine leukemia virus (MuLV) was examined by using unfrozen virus preparations harvested for 1 h. In this assay several mouse sera significantly and consistently neutralized MuLV infectivity. The ability of these sera to neutralize was correlated with the presence of antibodies against MuLV detectable in a radioimmune precipitation assay using radioactively labeled intact virions. This neutralization was specific, in that either N- or B-tropic viruses, but not Friend MuLV, were neutralized. In addition, neutralization could be abrogated with purified AKR MuLV gp71 at concentrations that do not interfere with virus infectivity but could not be abrogated with Rauscher MuLV gp71. Neutralizing activity could be removed by absorption with intact AKR MuLV, but not by absorption with Friend MuLV, a BALB/c xenotropic virus, or with NZB xenotropic virus. All the neutralizing activity of (B6C3)F1 mouse sera was associated with the immunoglobulin G fraction.

Full text

PDF
977

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Aaronson S. A., Stephenson J. R. Widespread natural occurrence of high titers of neutralizing antibodies to a specific class of endogenous mouse type-C virus. Proc Natl Acad Sci U S A. 1974 May;71(5):1957–1961. doi: 10.1073/pnas.71.5.1957. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Bassin R. H., Tuttle N., Fischinger P. J. Isolation of murine sarcoma virus-transformed mouse cells which are negative for leukemia virus from agar suspension cultures. Int J Cancer. 1970 Jul 15;6(1):95–107. doi: 10.1002/ijc.2910060114. [DOI] [PubMed] [Google Scholar]
  3. Bassin R. H., Tuttle N., Fischinger P. J. Rapid cell culture assay technic for murine leukaemia viruses. Nature. 1971 Feb 19;229(5286):564–566. doi: 10.1038/229564b0. [DOI] [PubMed] [Google Scholar]
  4. Chattopadhyay S. K., Rowe W. P., Teich N. M., Lowy D. R. Definitive evidence that the murine C-type virus inducing locus Akv-1 is viral genetic material. Proc Natl Acad Sci U S A. 1975 Mar;72(3):906–910. doi: 10.1073/pnas.72.3.906. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Cheung K. S., Smith R. E., Stone M. P., Joklik W. K. Comparison of immature (rapid harvest) and mature Rous sarcoma virus particles. Virology. 1972 Dec;50(3):851–864. doi: 10.1016/0042-6822(72)90439-4. [DOI] [PubMed] [Google Scholar]
  6. Fischinger P. J., Ihle J. N., Bolognesi D. P., Schäfer W. Inactivation of murine xenotropic oncornavirus by normal mouse sera is not immunoglobulin-mediated. Virology. 1976 May;71(1):346–351. doi: 10.1016/0042-6822(76)90118-5. [DOI] [PubMed] [Google Scholar]
  7. Fischinger P. J., Sch5AAFER W., Bolognesi D. P. Neutralization of homologous and heterologous oncornaviruses by antisera against the p15(E) and gp71 polypeptides of Friend murine leukemia virus. Virology. 1976 May;71(1):169–184. doi: 10.1016/0042-6822(76)90103-3. [DOI] [PubMed] [Google Scholar]
  8. GROSS L. Pathogenic properties, and "vertical" transmission of the mouse leukemia agent. Proc Soc Exp Biol Med. 1951 Oct;78(1):342–348. doi: 10.3181/00379727-78-19068. [DOI] [PubMed] [Google Scholar]
  9. Hanna M. G., Jr, Ihle J. N., Batzing B. L., Tennant T. W., Schenley C. K. Assessment of reactivities of natural antibodies to endogenous RNA tumor virus envelope antigens and virus-induced cell surface antigens. Cancer Res. 1975 Jan;35(1):164–171. [PubMed] [Google Scholar]
  10. Ihle J. N., Denny T. P., Bolognesi D. P. Purification and serological characterization of the major envelope glycoprotein from AKR murine leukemia virus and its reactivity with autogenous immune sera from mice. J Virol. 1976 Mar;17(3):727–736. doi: 10.1128/jvi.17.3.727-736.1976. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. Ihle J. N., Domotor J. J., Jr, Bengali K. M. Characterization of the type and group specificities of the immune response in mice to murine leukemia viruses. J Virol. 1976 Apr;18(1):124–131. doi: 10.1128/jvi.18.1.124-131.1976. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. Ihle J. N., Hanna M. G., Jr, Roberson L. E., Kenney F. T. Autogenous immunity to endogenous RNA tumor virus. Identification of antibody reactivity to select viral antigens. J Exp Med. 1974 Jun 1;139(6):1568–1581. doi: 10.1084/jem.139.6.1568. [DOI] [PMC free article] [PubMed] [Google Scholar]
  13. Ihle J. N., Jr, Hanna M. G., Schafer W., Hunsmann G., Bolognesi D. P., HUPER G. Polypeptides of mammalian oncornaviruses. III. Localization of p 15 and reactivity with natural antibody. Virology. 1975 Jan;63(1):60–67. doi: 10.1016/0042-6822(75)90370-0. [DOI] [PubMed] [Google Scholar]
  14. Ihle J. N., Yurconic M., Jr, Hanna M. G., Jr Autogenous immunity to endogenous RNA tumor virus. Radioimmune precipitation assay of mouse serum antibody levels. J Exp Med. 1973 Jul 1;138(1):194–208. doi: 10.1084/jem.138.1.194. [DOI] [PMC free article] [PubMed] [Google Scholar]
  15. Lee J. C., Hanna M. G., Jr, Ihle J. N., Aaronson S. A. Autogenous immunity to endogenous RNA tumor virus: differential reactivities of immunoglobulins M and G to virus envelope antigens. J Virol. 1974 Oct;14(4):773–781. doi: 10.1128/jvi.14.4.773-781.1974. [DOI] [PMC free article] [PubMed] [Google Scholar]
  16. Levy J. A., Ihle J. N., Oleszko O., Barnes R. D. Virus-specific neutralization by a soluble non-immunoglobulin factor found naturally in normal mouse sera. Proc Natl Acad Sci U S A. 1975 Dec;72(12):5071–5075. doi: 10.1073/pnas.72.12.5071. [DOI] [PMC free article] [PubMed] [Google Scholar]
  17. Lilly F., Duran-Reynals M. L., Rowe W. P. Correlation of early murine leukemia virus titer and H-2 type with spontaneous leukemia in mice of the BALB/c times AKR cross: a genetic analysis. J Exp Med. 1975 Apr 1;141(4):882–889. [PMC free article] [PubMed] [Google Scholar]
  18. Martin S. E., Martin W. J. Naturally occurring cytotoxic tumour reactive antibodies directed against type C viral envelope antigens. Nature. 1975 Aug 7;256(5517):498–499. doi: 10.1038/256498a0. [DOI] [PubMed] [Google Scholar]
  19. Meier H., Taylor B. A., Cherry M., Buebner R. J. Host-gene control of type-C RNA tumor virus expression and tumorigenesis in inbred mice. Proc Natl Acad Sci U S A. 1973 May;70(5):1450–1455. doi: 10.1073/pnas.70.5.1450. [DOI] [PMC free article] [PubMed] [Google Scholar]
  20. Nowinski R. C. Genetic control of natural immunity to ecotropic mouse leukemia viruses: immune response genes. Infect Immun. 1976 Apr;13(4):1098–1102. doi: 10.1128/iai.13.4.1098-1102.1976. [DOI] [PMC free article] [PubMed] [Google Scholar]
  21. Nowinski R. C., Kaehler S. L. Antibody to leukemia virus: widespread occurrence in inbred mice. Science. 1974 Sep 6;185(4154):869–871. doi: 10.1126/science.185.4154.869. [DOI] [PubMed] [Google Scholar]
  22. Nowinski R. C., Klein P. A. Anomalous reactions of mouse alloantisera with cultured tumor cells. II. Cytotoxicity is caused by antibodies to leukemia viruses. J Immunol. 1975 Nov;115(5):1261–1268. [PubMed] [Google Scholar]
  23. Rowe W. P., Hartley J. W., Lander M. R., Pugh W. E., Teich N. Noninfectious AKR mouse embryo cell lines in which each cell has the capacity to be activated to produce infectious murine leukemia virus. Virology. 1971 Dec;46(3):866–876. doi: 10.1016/0042-6822(71)90087-0. [DOI] [PubMed] [Google Scholar]
  24. Schafer W., Hunsmann G., Moennig V., Noranha F., Bolognesi D. P., Green R. W., Hüper G. Polypeptides of mammalian oncornaviruses. II Characterization of murine leukemia virus polypeptide (p 15) bearing interspecies reactivity. Virology. 1975 Jan;63(1):48–59. doi: 10.1016/0042-6822(75)90369-4. [DOI] [PubMed] [Google Scholar]
  25. Seifert E., Claviez M., Frank H., Hunsmann G., Schwarz H., Schäfer W. XII. Produktion grösserer Mengen von Friend-Virus durch eine permanente Zell-Suspensions-Kultur (Eveline-Suspensions-Zellen) Z Naturforsch C. 1975 Sep-Oct;30(5):698–700. [PubMed] [Google Scholar]
  26. Smith R. E. High specific infectivity avian RNA tumor viruses. Virology. 1974 Aug;60(2):543–547. doi: 10.1016/0042-6822(74)90348-1. [DOI] [PubMed] [Google Scholar]
  27. Steeves R. A., Strand M., August J. T. Structural proteins of mammalian oncogenic RNA viruses: murine leukemia virus neutralization by antisera prepared against purified envelope glycoprotein. J Virol. 1974 Jul;14(1):187–189. doi: 10.1128/jvi.14.1.187-189.1974. [DOI] [PMC free article] [PubMed] [Google Scholar]
  28. Stephenson J. R., Peters R. L., Hino S., Donahoe R. M., Long L. K., Aaronson S. A., Kelloff G. J. Natural immunity in mice to structural polypeptides of endogenous type C RNA viruses. J Virol. 1976 Sep;19(3):890–898. doi: 10.1128/jvi.19.3.890-898.1976. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Journal of Virology are provided here courtesy of American Society for Microbiology (ASM)

RESOURCES